Paul Young and colleagues recently published a meta-analysis that was designed to answer the question – does any group of patients benefit from fever control? The research question was: Since fever is physiologically costly, do patients “with limited physiologic reserves” benefit from reducing fever? The short answer, even for these … Continue reading Treat Nobody’s Fever? Podcast #38